Adrian Gottschalk
2021
In 2021, Adrian Gottschalk earned a total compensation of $4.3M as President and Chief Executive Officer at Foghorn Therapeutics, a 64% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $405,000 |
|---|---|
| Option Awards | $3,370,482 |
| Salary | $540,000 |
| Total | $4,315,482 |
Gottschalk received $3.4M in option awards, accounting for 78% of the total pay in 2021.
Gottschalk also received $405K in non-equity incentive plan and $540K in salary.
Rankings
In 2021, Adrian Gottschalk's compensation ranked 3,075th out of 12,415 executives tracked by ExecPay. In other words, Gottschalk earned more than 75.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,075 out of 12,415 | 75th |
Division Manufacturing | 1,230 out of 5,501 | 78th |
Major group Chemicals And Allied Products | 493 out of 2,371 | 79th |
Industry group Drugs | 435 out of 2,092 | 79th |
Industry Pharmaceutical Preparations | 296 out of 1,542 | 81st |
Source: SEC filing on April 29, 2022.
Gottschalk's colleagues
We found three more compensation records of executives who worked with Adrian Gottschalk at Foghorn Therapeutics in 2021.